Unmasking ATTR-CM: How It’s Detected, Who’s at Risk, and What Treatments Do—and Don’t—Do

Diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) is challenging because its symptoms are vague and overlap with many conditions. Providers typically follow a stepwise approach that combines history-taking, targeted testing, and imaging…

Continue Reading Unmasking ATTR-CM: How It’s Detected, Who’s at Risk, and What Treatments Do—and Don’t—Do